|
2025
|
Invention
|
Crystalline form of (r)-1-(3-(3-(4-aminopyrimidin-2-yl)-5-chlorophenyl)morpholino)prop-2-en-1-one... |
|
|
Invention
|
Method for catalytically synthesizing single chiral 2-aryl-substituted nitrogen heterocyclic deri... |
|
2024
|
P/S
|
Pharmaceutical products for the treatment of cancer Providing a website featuring blogs and non-d... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer and immune disorders Providing a website feat... |
|
|
Invention
|
Ras-pi3k inhibitors and uses thereof. Compounds of formula (I) and methods for modulating RAS-PI3K. |
|
|
Invention
|
Ras-pi3k inhibitors for the treatment of cancer and immunological diseases. The application relat... |
|
|
Invention
|
(e)-2-(benzylamino)-n-(3-(methylsulfonyl)allyl)-benzamide derivatives and similar compounds as ja... |
|
|
Invention
|
Keap1 inhibitors and uses thereof.
Compounds and methods for activating Nrf2 by inhibiting KEAP1. |
|
|
Invention
|
Keap1 inhibitors for use in the treatment of immunological disorders. Compounds and methods for a... |
|
|
Invention
|
Compounds and methods for modulating stat3.
Compounds and methods for inhibiting STAT3. |
|
|
Invention
|
2-azaspiro[3.3]heptane derivatives as stat3 inhibitors for the treatment of cancer. The present i... |
|
|
Invention
|
Compounds and methods for modulating ras-pi3k.
Compounds and methods for modulating RAS-PI3K. |
|
|
Invention
|
Compounds and methods for modulating ras-pi3k. Compounds and methods for modulating RAS-PI3K. |
|
|
Invention
|
1-(([1, 1',-biphenyl]-2-yl)sulfonyl)-4-fluoro-n-(3-(methylsulfonyl)allyl)piperidine-4-carboxamide... |
|
2023
|
Invention
|
Inhibitors and uses thereof.
Compounds and methods for inhibiting Nrf2 by activating KEAP1. |
|
|
Invention
|
N-acryloylmorpholine derivatives as keap1 modulators and uses thereof. Compounds and methods for ... |
|
|
Invention
|
N-acryloylmorpholine derivatives as keap1 modulators and uses thereof |
|
|
Invention
|
Pharmaceutical compositions comprising wrn helicase inhibitors. Disclosed are compounds of Formul... |
|
|
Invention
|
Pharmaceutical compositions comprising wrn helicase inhibitors.
Disclosed are compounds of Formu... |
|
|
Invention
|
Pharmaceutical compositions comprising wrn helicase inhibitors |
|
2022
|
Invention
|
Compounds selective for jak1 and methods of use.
Disclosed herein are compounds selective for JA... |
|
|
Invention
|
Compounds selective for jak1 and methods of use. Disclosed herein are compounds selective for JAK... |
|
|
Invention
|
In vivo engineered cereblon protein.
Disclosed herein are in vivo engineered cereblon protein an... |
|
2021
|
P/S
|
Drug discovery services; pharmaceutical drug development services; pharmaceutical research and de... |
|
|
P/S
|
Drug discovery services; Pharmaceutical drug development services; Pharmaceutical research and de... |
|
2020
|
Invention
|
Cereblon modulators and uses thereof. Disclosed herein are compositions and methods for modulatin... |
|
|
Invention
|
Compounds and methods for modulating immune-related proteins.
Disclosed herein are methods, phar... |
|
|
Invention
|
Compounds and methods for modulating immune-related proteins. Disclosed herein are methods, pharm... |
|
2019
|
Invention
|
Substituted isoindolinones as modulators of cereblon-mediated neo-substrate recruitment.
Disclos... |
|
|
Invention
|
Substituted isoindolinones as modulators of cereblon-mediated neo-substrate recruitment. Disclose... |
|
|
Invention
|
In vivo engineered cereblon protein. Disclosed herein are in vivo engineered cereblon protein and... |
|
2018
|
Invention
|
Compounds and methods of modulating protein degradation.
Disclosed herein are protein-probe addu... |
|
|
Invention
|
Compounds and methods of modulating protein degradation. Disclosed herein are protein-probe adduc... |
